Gilead Sciences, Inc.
Source: SEC Form 13F · as of Mar 2026Gilead Sciences, Inc. holds 2 biotech & pharma companies tracked by BioSniper, totaling $803.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
2
Total value held
$803.8M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Arcus Biosciences, Inc. (RCUS)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| RCUSArcus Biosciences, Inc. | 31,424,760 | $678.8M |
| ASMBASSEMBLY BIOSCIENCES, INC. | 4,505,391 | $125.0M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.